SignaIDT Biotechnologies (SZ), Inc.won the 2017 Shenzhen International Holdings Biological/Life Health Industry Innovation Gold Award

Time:

2017-12-02 00:00

【2017-09-25】The 2017 Shenzhen International Biological/Life and Health Industry Exhibition, sponsored by the Shenzhen Municipal Government and organized by the Municipal Trade Promotion Committee and the Municipal Development and Reform Commission, was held on It ended successfully on September 23. Our company participated in the exhibition with its innovative series of "new generation of dry molecular detection reagents without cold chain", and won the gold award of "2017 Bio/Life and Health Industry Innovation Achievements".

As a major event in the field of biology/life health, more than 300 well-known bio-enterprises from all over the world participated in this exhibition, attracting nearly 30,000 professional visitors from all over the country to attend. Focusing on biology and life health, this exhibition has gathered domestic and foreign biological and life health industry resources, not only leading the new trend of the future development of the big health industry, but also enhancing the professionalism and influence of Shenzhen's biology and life health industry .

The innovative series of dry molecular detection reagents exhibited by our company overcome many shortcomings of liquid reagents, do not need cold chain transportation and storage, and avoid the problems caused by cold chain failure, repeated freezing and thawing, pipetting errors, aerosol pollution, etc. The loss is greatly reduced, the cost is greatly reduced, and it is easy to use. It is especially suitable for primary medical institutions with poor cold chain conditions, filling the domestic gap and reaching the international advanced level. In the evaluation of innovative achievements in this exhibition, our company stood out among more than 300 exhibitors and won the gold medal, ranking the top 5. General Manager Dr. Lin Jingzhong also gave a keynote speech on "Development and Production of a New Generation of Dry Molecular In Vitro Diagnostic Reagents" at the conference on behalf of the company, which aroused widespread attention from investment institutions and participants.

Related News